A CoxPH analysis fitted against GPC4 expression values exhibited a statistically significant association between high GPC4 levels and a poor prognosis in glioma, glioblastoma, pancreatic carcinoma, and uveal melanoma, suggesting its potential as a prognostic factor. Here, GPC4 is linked to glioma.